Healthcare Press

Telemedicine Treatment Doubles HCV Cure Rates in Opioid Treatment Programs

  • 📰 Medscape
  • ⏱ Reading Time:
  • 43 sec. here
  • 8 min. at publisher
  • 📊 Quality Score:
  • News: 42%
  • Publisher: 55%

Health News

Telemedicine,Opioid Treatment Program,HCV

A new study shows that patients with opioid use disorder (OUD) who received facilitated telemedicine treatment within their opioid treatment program were twice as likely to be treated and cured of HCV compared to those referred for off-site treatment. The study also found a significant decrease in illicit drug use among cured patients and few reinfections.

) were twice as likely to be treated and cured of HCV if they received facilitated telemedicine treatment within their opioid treatment program than if they were referred for off-site treatment, the results of a new study showed.

In a prospective cluster randomized clinical trial, Talal and colleagues assessed the impact of embedding facilitated telemedicine for HCV care into 12 opioid treatment programs in New York State. Telemedicine participants had an initial telemedicine encounter facilitated by study case managers onsite who also administered a blood test. The telemedicine clinician subsequently evaluated participants and ordered direct-acting antiviral medication that was delivered to the opioid treatment program monthly and dispensed along withIn the telemedicine group, 268 of 290 individuals initiated HCV treatment compared with 126 of 312 in the referral group.

In addition, illicit drug use decreased significantly among cured patients in both the telemedicine group . Adults in both groups rated healthcare delivery satisfaction as high or very high.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 386. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Integrating Telemedicine for HCV With Opioid Use Disorder Treatment WorksIntegrating HCV treatment into opioid treatment programs improves access to HCV treatment, leading to high cure rates, new research shows.
Source: Medscape - 🏆 386. / 55 Read more »

Patient Enrollment in Cancer Clinical Trials Doubles, but Overall Participation Remains LowNew estimates show that patient enrollment in cancer clinical trials focused on treatments is about twice as high now compared with past estimates, with rates at National Cancer Institute–designated centers reaching more than 20%. Still, the overall rate of clinical trial participation remains low and is influenced by the institution where patients receive care.
Source: Medscape - 🏆 386. / 55 Read more »